New limits on doctors in training in the United Kingdom (U.K.) have drastically reduced the amount of training they receive and may put patients in peril, a renowned retired British surgeon told listeners here on April 29 at the Annual Meeting of the Triological Society, held as part of the Combined Otolaryngology Spring Meetings.
Physicians have noted the potential for dizziness in migraine patients since the 19th century. And yet the 21st century has so far failed to bring any unifying definition to a symptom that is frustratingly diffuse in its intensity and frequency and unclear in its origins.
Harold Pillsbury, MD, chair of otolaryngology-head and neck surgery at the University of North Carolina School of Medicine in Chapel Hill, is known as one of the more colorful figures in his field, with a bright smile—usually accompanied by a bow tie—and a forthright demeanor.
Triological Society President Gerald Berke, MD, turned to the words of science greats in his President’s Address, delivering an inspirational talk on scientific research at the society’s Annual Meeting, held here on April 29 as part of the Combined Otolaryngology Spring Meetings.
Regarding the article, “Otolaryngologist Pioneers New Practice Model: Dr. Russell heralds hospitalist role as others ponder the concept’s staying power”…
For decades, otolaryngologists have been frustrated by the refusal of some patients with hearing loss to use hearing aids. Statistics on noncompliance vary, but there is general agreement that only about 20 percent to 25 percent of Americans with treatable hearing loss use hearing aids. The problem seems to be more acute for people with mild hearing loss: A consumer survey conducted by the nonprofit Better Hearing Institute in 2009 found that fewer than 10 percent of people with mild hearing loss use amplification and that even among people with moderate-to-severe hearing loss, only four in 10 use amplification.
A little over a year ago, I wrote an op-ed piece for ENT Today titled, “The Gender Gap in Otolaryngology: How do we make it disappear?” (February 2010). I challenged our specialty to find innovative and inclusive ways to tap into the extraordinary pool of talent found in our women otolaryngologists. And thanks to some extraordinarily enlightened leadership, we did it! Way beyond all hopes and expectations, the men and women of our specialty have paved the way for meaningful and fruitful change.
If you think your patients are finding your otolaryngology practice by looking in the Yellow Pages, think again. Increasingly, patients are deciding which physician to call by visiting the web and reading feedback on sites like vitals.com, healthgrades.com, lifescript.com and drscore.com.
When it comes to treating head and neck tumors, the more information that is available, the better. In the past, options for investigating these types of tumors and their aggressiveness were limited. But advances in optical imaging, positron emission tomography (PET) scanning, magnetic resonance imaging (MRI) and fluorescent and ultrasound imaging have some otolaryngologists excited about the prospect of getting a better look at head and neck cancer.
A 14-year-old boy sustained blunt trauma to the forehead from a foul-tipped baseball. Significant past medical history consisted of allergic rhinitis treated with over-the-counter cetirizine (Zyrtec). On examination, the patient had right frontal sinus depression with overlying edema. There were no palpable nasal bone or orbital rim abnormalities. Baseball threads were seen on the overlying skin as well as ecchymosis on the nasal dorsum and under both eyes.